There is no doubt that navigating medical device regulations can be daunting. Luckily, Nottingham Spirk has a golden track record, and we are here to help.

Nottingham Spirk's Director of Insights Amanda Beacher was recently quoted by Clinical Trials Arena regarding the FDA's new guidance on patient advisors.